cc-486
Cc 486 is a drug used to treat Carcinoma, Non-Small-Cell Lung, Myelodysplastic Syndromes, Acute Myeloid Leukemia, and other conditions. Cc 486 is being actively studied in 12 studies and prior, has been studied in 5.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Celgene | Istituto Nazionale Dei Tumori | Valeria Santini |
AbbVie | MD Anderson Cancer Center | |
Gilead Sciences | Centre Rene Gauducheau Centre de Lutte Contre Le Cancer Nantes Atlantique |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
H
Recruiting
- Non Hodgkin Lymphoma
- +3 more
- CC-486
- Duvelisib
- Tampa, FloridaMoffitt Cancer Center
2022-03-14
Mar 14, 2022T
Completed
- Epithelial Ovarian Cancer
- CC-486
- Pembrolizumab
- Los Angeles, California
- +3 more
2021-09-22
Sep 22, 2021M
Recruiting
- Plasmacytoma
- +2 more
- CC-486
- +2 more
- Basking Ridge, New Jersey
- +6 more
2021-12-01
Dec 1, 2021C
Approved for marketing
- Acute Myelogenous Leukemia (AML)
- CC-486
- Summit, New JerseyCelgene
2020-09-16
Sep 16, 2020C
Active, not recruiting
- Hematologic Neoplasm
- Neoplasms
- CC-486
- Gainesville, Florida
- +2 more
2021-12-02
Dec 2, 2021C
Recruiting
- Leukemia, Myeloid, Acute
- CC-486
- Venetoclax
- Stanford, California
- +8 more
2021-11-15
Nov 15, 2021U
Recruiting
- Follicular Lymphoma
- Venetoclax
- +2 more
- Chicago, IllinoisUniversity of Chicago Medical Center
2021-11-12
Nov 12, 2021C
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- CC-486
- +2 more
- Glendale, Arizona
- +32 more
2022-01-21
Jan 21, 2022G
Recruiting
- Myeloid Malignancies
- Magrolimab
- +6 more
- Birmingham, Alabama
- +12 more
2022-04-06
Apr 6, 2022K
Active, not recruiting
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- CC-486
- Newcastle, New South Wales, Australia
- +10 more
2022-03-29
Mar 29, 2022U
Recruiting
- MDS
- CMML
- CC-486
- Florence, ItalyAOU Careggi- University of Florence
2021-03-16
Mar 16, 2021C
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- nab-paclitaxel IV
- +2 more
- San Francisco, California
- +33 more
2022-01-24
Jan 24, 2022C
Completed
- Urinary Bladder Neoplasms
- +7 more
- CC-486
- +2 more
- Scottsdale, Arizona
- +12 more
2019-11-07
Nov 7, 2019C
Completed
- Hematological Neoplasms
- +19 more
- CC-486
- Vidaza
- Scottsdale, Arizona
- +9 more
2020-05-11
May 11, 2020A
Recruiting
- Acute Myeloid Leukemia (AML)
- Venetoclax
- +3 more
- Mobile, Alabama
- +234 more
2022-03-08
Mar 8, 2022C
Completed
- Nasopharyngeal Neoplasms
- CC-486
- Atlanta, Georgia
- +24 more
2018-11-20
Nov 20, 2018C
C
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- CC-486
- New York, New York
- +4 more
2018-10-22
Oct 22, 2018